Paper11891783
The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease.
Barker PA and 1 other. J Neurosci Res, 2002. Cited by 264 papers, by iCite.
Cite this record
ConductScience Library. The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease. Papers, record 11891783. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11891783
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apoptosis | Major topic |
| Cell Cycle | Major topic |
| Neoplasm Proteins | Major topic |
| Prader-Willi Syndrome | Major topic |
| Animals | |
| Antigens, Neoplasm | |
| Carrier Proteins | |
| DNA-Binding Proteins | |
| Humans | |
| Melanoma-Specific Antigens | |
| Molecular Sequence Data | |
| Nerve Tissue Proteins | |
| Nuclear Proteins | |
| Sequence Homology, Amino Acid |
Source PubMed
Cited by140
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 264 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42084830 | Oncogenic MAGEA4 directs neuroendocrine differentiation and survival in prostate cancer cells through the SIRT1/Acetyl-p53/BCL-2 axis. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42084830 | PubMed |
| 41843279 | Comprehensively exploring the roles of MAGEA1 in cryptorchidism and its related transcription factor regulatory network. | J Mol Histol | 2026 | https://conductscience.org/library/papers/41843279 | PubMed |
| 41133217 | Coupling of stemness maintenance with cell cycle control in stem cells. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/41133217 | PubMed |
| 40937506 | Development of Next Generation Cell-Permeable Peptide Inhibitors for the Oncological Target MAGE-A4. | J Med Chem | 2025 | https://conductscience.org/library/papers/40937506 | PubMed |
| 40549114 | Enhanced Therapeutic Effects of Extracellular Vesicles Targeting MiR-137 Contribute to Functional Recovery by Attenuating Neuronal Injury After Ischemic Stroke. | Neurosci Bull | 2026 | https://conductscience.org/library/papers/40549114 | PubMed |
| 40241383 | Exploring methylation signatures for high de novo recurrence risk in hepatocellular carcinoma. | Clin Mol Hepatol | 2025 | https://conductscience.org/library/papers/40241383 | PubMed |
| 40218304 | Preliminary Exploration of MAGE-B1, -B4, -B5, and -B10 mRNA Expression in Canine Mammary Tumors in Dogs. | Animals (Basel) | 2025 | https://conductscience.org/library/papers/40218304 | PubMed |
| 40048253 | Investigation of a mouse model of Prader-Willi Syndrome with combined disruption of Necdin and Magel2. | JCI Insight | 2025 | https://conductscience.org/library/papers/40048253 | PubMed |
| 39409926 | ANKRD1 Promotes Breast Cancer Metastasis by Activating NF-κB-MAGE-A6 Pathway. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39409926 | PubMed |
| 39125568 | An Immunohistochemical Study of MAGE Proteins in Hepatocellular Carcinoma. | Diagnostics (Basel) | 2024 | https://conductscience.org/library/papers/39125568 | PubMed |
| 39061557 | Evolutionary and Expression Analysis of the Pig MAGE Gene Family. | Animals (Basel) | 2024 | https://conductscience.org/library/papers/39061557 | PubMed |
| 38448672 | Structural basis for RAD18 regulation by MAGEA4 and its implications for RING ubiquitin ligase binding by MAGE family proteins. | EMBO J | 2024 | https://conductscience.org/library/papers/38448672 | PubMed |
| 38438725 | RNA m6A methylation and regulatory proteins in pulmonary arterial hypertension. | Hypertens Res | 2024 | https://conductscience.org/library/papers/38438725 | PubMed |
| 37655157 | Genome instability-derived genes as a novel prognostic signature for lung adenocarcinoma. | Front Cell Dev Biol | 2023 | https://conductscience.org/library/papers/37655157 | PubMed |
| 37439567 | SARS-CoV-2 main protease cleaves MAGED2 to antagonize host antiviral defense. | mBio | 2023 | https://conductscience.org/library/papers/37439567 | PubMed |
| 37365889 | Restin protein expression in non-small cell lung cancer. | Thorac Cancer | 2023 | https://conductscience.org/library/papers/37365889 | PubMed |
| 37181643 | MAGED4B is a Poor Prognostic Marker of Stomach Adenocarcinoma and a Potential Therapeutic Target for Stomach Adenocarcinoma Tumorigenesis. | Int J Gen Med | 2023 | https://conductscience.org/library/papers/37181643 | PubMed |
| 37144487 | Cancer testis antigen subfamilies: Attractive targets for therapeutic vaccine (Review). | Int J Oncol | 2023 | https://conductscience.org/library/papers/37144487 | PubMed |
| 36980665 | The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy? | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36980665 | PubMed |
| 36291836 | Virtual Screening and Quantitative Structure-Activity Relationship of Moringa oleifera with Melanoma Antigen A (MAGE-A) Genes against the Therapeutics of Non-Small Cell Lung Cancers (NSCLCs). | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36291836 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MAGED1 | 9500 | PubTator's text mining | https://conductscience.org/library/genes/9500 | NCBI Gene |
| NDN | 4692 | PubTator's text mining | https://conductscience.org/library/genes/4692 | NCBI Gene |
| XIAP | 331 | PubTator's text mining | https://conductscience.org/library/genes/331 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11891783
GET https://conductscience.org/api/papers/v1/11891783/cited_by?page=2